After cashing out more than $1 billion from his early Facebook investment and successfully bankrupting an independent media company, what’s a billionaire venture capitalist to do? Serve on the Supreme Court, apparently. The Huffington Post reported Thursday that PayPal and Palantir co-founder Peter Thiel is telling friends that Donald Trump would nominate him to the Supreme Court if he becomes president. Trump “deeply loves Peter Thiel,” one source says. (Spokespeople for both Trump and Thiel have denied the report. “Peter hasn’t had any conversations about a Supreme Court nomination and has no interest in the job,” a Thiel spokesperson said; Trump press secretary Hope Hicks also offered a flat-out denial.)

Thiel, a noted libertarian, is the only prominent Silicon Valley leader publicly supporting Donald Trump. He served as a California state delegate for Trump, and spoke on his behalf at the Republican National Convention in July. Most recently, he penned an editorial for The Washington Post that was mainly a screed against the Washington, D.C., metro system, but was also ostensibly a piece of writing in support of a Trump presidency.

The relationship between the two, while at first perplexing, does make some measure of sense. Both men are wealthy capitalists with an aversion to political correctness. Both are also litigious; Thiel bankrolled the lawsuit that bankrupted Gawker this summer, among other rumored lawsuits, while Trump has threatened to sue everyone from his memoir’s ghostwriter to TV host Bill Maher, over a joke about whether his father was an orangutan. At a minimum, Thiel could help deliver on Trump’s promise to “open up” libel laws to make it easier for people to sue journalists and media.

Thiel makes an appealing Supreme Court nominee for more sinister reasons, too.

Though he has some conservative tendencies and has donated to Republican candidates like Carly Fiorina in the past, Thiel, who attended Stanford Law School and briefly worked at New York law firm Sullivan & Cromwell, is also an outspoken libertarian. He firmly believes that monopolies are a good thing for society, and that college is a waste of time and money. (The Thiel Foundation funds a group of young adults under 22 years old every year to build new products and start-ups.) He’s also expressed his wishes for society to more closely resemble the way things were in the 1920s before the New Deal and the creation of the modern welfare state. “Since 1920, the vast increase in welfare beneficiaries and the extension of the franchise to women—two constituencies that are notoriously tough for libertarians—have rendered the notion of ‘capitalist democracy’ into an oxymoron,” he wrote in the libertarian journal Cato Unbound in 2009.

Thiel makes an appealing Supreme Court nominee for more sinister reasons, too. The 48-year-old is obsessed with radical life extension and overcoming the “inevitability of the death”; an endeavor that, if successful, could transform his Supreme Court life tenure into a potentially infinite appointment. As Thiel explained on Bloomberg TV in 2014, he was taking human-growth-hormone pills as part of his plan to live 120 years. “It helps maintain muscle mass, so you’re much less likely to get bone injuries, arthritis,” he said. But Thiel is also dreaming bigger. The billionaire is reportedly interested in parabiosis life-extension technology, including the practice of receiving blood transfusions from younger people as a means of improving his health and potentially reversing aging. “I’m looking into parabiosis stuff, which I think is really interesting. This is where they did the young blood into older mice and they found that had a massive rejuvenating effect,” he told Inc. magazine in 2015. “It’s one of these very odd things where people had done these studies in the 1950s and then it got dropped altogether. I think there are a lot of these things that have been strangely under-explored.” While Gawker previously reported receiving a tip that Thiel “spends $40,000 per quarter to get an infusion of blood from an 18-year-old based on research conducted at Stanford on extending the lives of mice,” Thiel said last year that he hadn’t “quite, quite started yet.” According to a spokesman for Thiel Capital who spoke with Inc., that remains the case.